Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-2,000
Closed -$150K – 270
2021
Q3
$150K Hold
2,000
– – 0.06% 232
2021
Q2
$155K Sell
2,000
-96
-5% -$7.14K 0.04% 240
2021
Q1
$155K Buy
+2,096
New +$155K 0.07% 214

Other funds holding MRK

Veracity Capital's MRK Position: Q3 2026 in Review

Veracity Capital opened a new position in Merck (MRK) in Q3 2026: 1,999 shares worth $290K. The stake represents 0.08% of the portfolio and ranks #180 among its holdings. This is a return to the name: Veracity Capital previously reported a position in MRK as recently as Q2 2025.

Veracity Capital first reported a position in MRK in Q4 2019 and has held it in 23 quarters since. The position peaked at $1.86M in Q2 2023. 203 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Veracity Capital held 1,999 shares of Merck worth $290K as of Q3 2026.
  • Merck was a new Veracity Capital position in Q3 2026.
  • Merck made up 0.08% of Veracity Capital's portfolio in Q3 2026, its #180 holding.
  • Veracity Capital first reported a position in Merck in Q4 2019 and has held it in 23 quarters since.
  • Veracity Capital's Merck position peaked at $1.86M in Q2 2023.
  • 203 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Veracity Capital's 13F filing for Q3 2026, filed 8 Oct 2026.